Streetbeat News

Products Services

ATVI

MSFT

SONY

SPY

Microsoft Corp (NASDAQ:MSFT) has seen significant growth since the release of its Xbox gaming console in 2001. An investment of $1,000 in Microsoft stock at the time of Xbox's release would be worth $10,139.77 today, a hypothetical return of 914%. This outperforms the same investment in the SPDR S&P 500 ETF (NYSE:SPY), which would be worth $4,020.90, and Sony Group Corp (NYSE:SONY), which would be worth $2,082.69. Microsoft continues to grow its gaming division, with plans to acquire Activision Blizzard (NASDAQ:ATVI).

Portfolio Pulse from Chris Katje

July 27, 2023 | 5:05 pm

NIO

TSLA

XPEV

Tesla has filed a U.S. Patent application for neural networks for embedded devices and plans to open a new showroom in Connecticut this fall. The showroom will be located on Mohegan tribal land, bypassing a law that bans direct-to-consumer automobile sales in Connecticut. Tesla shares are up more than 65% over the past year, while shares of Xpeng and Nio are up over 125% and 70% respectively.

Portfolio Pulse from Erica Kollmann

July 27, 2023 | 4:52 pm

URGN

UroGen Pharma Ltd's stock is surging after the company released positive topline data from its Phase 3 trials ATLAS and ENVISION studying UGN-102 for bladder cancer. Both trials met their primary endpoints, showing significant disease-free survival and complete response rates. The company also announced a private placement of approximately $120 million. URGN shares are up 42.70% at $12.86.

Portfolio Pulse from Vandana Singh

July 27, 2023 | 4:46 pm

LUV

Southwest Airlines' CEO has announced plans to fly Boeing's Max 7 model next year. However, if this is not possible, the airline will opt for the Max 8 model instead.

Portfolio Pulse from Happy Mohamed

July 27, 2023 | 4:41 pm

According to Bloomberg, Meta Platforms Inc. does not plan to charge most customers for its LLaMA2 service.

Portfolio Pulse from Happy Mohamed

July 27, 2023 | 4:41 pm

META

RBLX

Roblox has announced the open beta availability of its platform on Meta Quest 2 and Quest Pro via App Lab. This move allows users to optimize their experiences for Meta Quest VR devices.

Portfolio Pulse from Happy Mohamed

July 27, 2023 | 4:31 pm

FEMY

Femasys Inc's shares are trading higher after the US Patent and Trademark Office issued a Notice of Allowance for a patent application related to the company's therapeutic product candidate, FemBloc. The patent strengthens Femasys' intellectual property position and coverage for FemBloc, a nonsurgical, non-implant, in-office solution for permanent birth control. The company expects the patent, when issued, to expire in 2039 at the earliest. Femasys' shares are up 108.80% at $0.80.

Portfolio Pulse from Vandana Singh

July 27, 2023 | 4:26 pm

LPCN

Lipocine Inc's stock is trading higher after the company released positive topline results from a Phase 2 clinical study of LPCN 1148, a drug under development for the clinical management of cirrhosis. The study showed that patients treated with LPCN 1148 experienced significantly fewer cases of hepatic encephalopathy and reported significant improvement in symptoms. The drug was well-tolerated with adverse event rates similar to placebo.

Portfolio Pulse from Vandana Singh

July 27, 2023 | 4:22 pm

ASXC

CTCX

FEMY

META

MRSN

NOA

TPIC

U.S. stocks traded higher with the Nasdaq Composite gaining around 1%. Meta Platforms, Inc. (NASDAQ:META) shares jumped 7% after reporting better-than-expected Q2 results. Carmell Therapeutics Corporation (NASDAQ:CTCX) shares shot up 41% after announcing a merger with Axolotl Biologix. Femasys Inc. (NASDAQ:FEMY) shares shot up 174% after the US Patent and Trademark Office issued a Notice of Allowance for FemBloc. North American Construction Group Ltd. (NYSE:NOA) shares were up 38% after posting better-than-expected Q2 results. Mersana Therapeutics, Inc. (NASDAQ:MRSN) shares dropped 77% after UPLIFT clinical trial did not meet primary endpoint. TPI Composites, Inc. (NASDAQ:TPIC) shares were down 35% after lowering its 2023 forecast. Asensus Surgical, Inc. (NYSE:ASXC) shares fell 35% after reporting a $10 million registered direct offering.

Portfolio Pulse from Lisa Levin

July 27, 2023 | 4:16 pm

RSLS

Reshape Lifesciences has received a notice of allowance for its U.S. patent application 16/993,110 titled 'Pressure Control System For Intragastric Device (For The Treatment Of Obesity)'.

Portfolio Pulse from Happy Mohamed

July 27, 2023 | 4:04 pm